Press Release: Covista Announces Third Quarter Fiscal Year 2026 Conference Call

Dow Jones
04/07
CHICAGO--(BUSINESS WIRE)--April 07, 2026-- 

Covista (the "company" or "Covista") $(CVSA)$, the largest healthcare educator in the United States, announced today it will release its third quarter fiscal year 2026 results on Thursday, May 7, 2026, after market close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results.

This call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Covista earnings call" or by using conference ID: 13759299. The call will be simulcast through the Covista investor relations website at: https://investors.covista.com. Covista will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13759299, or visit the Covista investor relations website.

About Covista

Covista is America's largest healthcare educator, serving more than 97,000 students and supported by a community of 385,000 alumni across five accredited institutions. Through personalized, tech-enabled education powered by 10,000 faculty and colleagues, Covista expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale. Covista is the parent company of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. For more information, visit covista.com and follow us on LinkedIn, Instagram and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260407534052/en/

 
    CONTACT:    Investor Contact: Jeremy Cohen, Investor.Relations@covista.com 

Media Contact: Maureen Bender, covistamedia@covista.com

 
 

(END) Dow Jones Newswires

April 07, 2026 08:03 ET (12:03 GMT)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10